Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
South Korea
· Delayed Price · Currency is KRW 6,340.00
-250.00 (-3.79%)
At close: Mar 31, 2025, 3:30 PM KST
Ahn-Gook Pharmaceutical Revenue
In the year 2024, Ahn-Gook Pharmaceutical had annual revenue of 271.12B KRW with 16.02% growth. Ahn-Gook Pharmaceutical had revenue of 70.69B in the quarter ending December 31, 2024, with 10.09% growth.
Revenue
271.12B
Revenue Growth
+16.02%
P/S Ratio
0.27
Revenue / Employee
677.79M
Employees
400
Market Cap
72.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 271.12B | 37.44B | 16.02% |
| Dec 31, 2023 | 233.68B | 28.29B | 13.77% |
| Dec 31, 2022 | 205.39B | 41.85B | 25.59% |
| Dec 31, 2021 | 163.53B | 20.17B | 14.07% |
| Dec 31, 2020 | 143.36B | -12.49B | -8.01% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Kia Corporation | 107.45T |
| Celltrion | 3,557.30B |
| KB Financial Group | 15.01T |